Skip to main content

Table 3 Comparison of the predictive performance of the five models in predicting Ki-67 expression

From: Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma

Models

AUC (95% CI)

Sensitivity (%)

Specificity (%)

Accuracy (%)

PPV (%)

NPV (%)

AP radiomics model

Training (nā€‰=ā€‰103)

0.873 (79.3ā€“93.0)

92.5 (74/80)

78.3 (18/23)

89.3 (92/103)

93.7 (74/79)

75.0 (18/24)

Validation (nā€‰=ā€‰48)

0.813 (67.4ā€“91.1)

81.3 (26/32)

81.3 (13/16)

81.3 (39/48)

89.7 (26/29)

68.4 (13/19)

Total (nā€‰=ā€‰151)

0.837 (76.8 89.2)

90.2 (101/112)

69.2 (27/39)

91.4 (138/151)

89.4 (101/113)

71.1 (27/38)

HBP radiomics model

Training (nā€‰=ā€‰103)

0.813 (72.4ā€“88.3)

98.8 (79/80)

47.8 (11/23)

87.4 (90/103)

86.8 (79/91)

91.7 (11/12)

Validation (nā€‰=ā€‰48)

0.740 (59.3ā€“85.6)

84.4 (27/32)

62.5 (10/16)

89.6 (43/48)

81.8 (27/33)

66.7 (10/15)

Total (nā€‰=ā€‰151)

0.793 (72.0-85.5)

87.5 (98/112)

59.0 (23/39)

80.1 (121/151)

86.0 (98/114)

62.2 (23/37)

T2W radiomics model

Training (nā€‰=ā€‰103)

0.889 (81.2ā€“94.4)

72.5 (58/80)

95.7 (22/23)

77.7 (80/103)

98.3 (58/59)

50.0 (22/44)

Validation (nā€‰=ā€‰48)

0.698 (54.9ā€“82.2)

90.6 (29/32)

43.8 (7/16)

75.0 (36/48)

76.3 (29/38)

70.0 (7/10)

Total (nā€‰=ā€‰151)

0.823 (75.2, 88.0)

67.9 (76/112)

68.4 (27/39)

68.2 (103/151)

86.4 (76/88)

42.9 (27/63)

Combined AP and HBP radiomics model

Ā Ā Ā Ā 

Training (nā€‰=ā€‰103)

0.880 (0.802ā€“0.936)

86.2 (69/80)

82.6 (19/23)

70.9 (73/103)

78.4 (69/88)

26.7 (4/15)

Validation (nā€‰=ā€‰48)

0.799 (0.658ā€“0.901)

75.0 (24/32)

75.0 (12/16)

75.0 (36/48)

85.7 (24/28)

60.0 (12/20)

Total (nā€‰=ā€‰151)

0.852 (78.5, 90.4)

83.9 (94/112)

76.9 (30/39)

82.1 (124/151)

91.3 (94/103)

62.5 (30/48)

Combined modela

Training (nā€‰=ā€‰103)

0.922 (0.852ā€“0.965)

98.7 (79/80)

78.3 (18/23)

94.2 (97/103)

94.0 (79/84)

94.7 (18/19)

Validation (nā€‰=ā€‰48)

0.863 (73.3ā€“94.5)

90.6 (29/32)

75.0 (12/16)

85.4 (41/48)

87.9 (29/33)

80.0 (12/15)

Total (nā€‰=ā€‰151)

0.806 (73.4ā€“86.6)

83.0 (93/112)

64.1 (25/39)

78.1 (118/151)

86.9 (93/107)

56.8 (25/44)

  1. APĀ alpha-fetoprotein, AUCĀ area under receiver operating characteristic curve, HBPĀ hepatobiliary phase, NPVĀ negative predictive value, PPVĀ positive predictive value
  2. aCombined model includes AP Rad-score and serum AFP level